Patents by Inventor Ferdinando Auricchio

Ferdinando Auricchio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148936
    Abstract: A scaffold for tissue regeneration, particularly for bone regeneration, comprises a three-dimensional supporting structure made of a biocompatible and biodegradable material; the supporting structure is functionalized with secretome, in particular mesenchymal stem cell secretome, preferably in lyophilized form (lyosecretome).
    Type: Application
    Filed: March 9, 2022
    Publication date: May 9, 2024
    Applicant: PHARMAEXCEED S.R.L.
    Inventors: Ferdinando Auricchio, Elia Bari, Michele Conti, Sara Perteghella, Franca Scocozza, Marzio Sorlini, Maria Luisa Torre
  • Patent number: 11560406
    Abstract: The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro)n-His-Pro-His-Ala-Arg-Ile-Lys]m-Y. The peptides are for medical use, in particular as anti-tumoral agents.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: January 24, 2023
    Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Ferdinando Auricchio, Antimo Migliaccio
  • Patent number: 11529751
    Abstract: A structure has a plurality of modules of cementitious material; a first module exhibiting a reciprocal coupling surface and hooking portions defining at least one cavity, a second module exhibiting a respective reciprocal coupling surface—countershaped and in contact with the reciprocal coupling surface of the first module—and a hooking portion defining at least one cavity extending along at least partially the stratification direction; a connecting element engaged, on one side, inside the cavity of the hooking portion of the first module and, on the other side, inside the cavity of the hooking portion of the second module. The connecting element is configured for stably constraining the first and second modules and holding these latter in contact with each other. Further, a process makes a structure of reinforced cementitious material.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: December 20, 2022
    Inventors: Domenico Asprone, Ferdinando Auricchio, Costantino Menna
  • Publication number: 20190329447
    Abstract: A structure has a plurality of modules of cementitious material; a first module exhibiting a reciprocal coupling surface and hooking portions defining at least one cavity, a second module exhibiting a respective reciprocal coupling surface—countershaped and in contact with the reciprocal coupling surface of the first module—and a hooking portion defining at least one cavity extending along at least partially the stratification direction; a connecting element engaged, on one side, inside the cavity of the hooking portion of the first module and, on the other side, inside the cavity of the hooking portion of the second module. The connecting element is configured for stably constraining the first and second modules and holding these latter in contact with each other. Further, a process makes a structure of reinforced cementitious material.
    Type: Application
    Filed: July 20, 2017
    Publication date: October 31, 2019
    Inventors: Domenico ASPRONE, Ferdinando AURICCHIO, Costantino MENNA
  • Patent number: 10400008
    Abstract: The invention provides a molecule that modulates an activity of a Src family kinase for use in preventing or treating a metastatic cancer a subject. Preferably, the molecule comprises or consists of the structure: Bj-[(Pro)n-Xr-His-Pro-His-Ala-Arg-Ile-Lys]m-Rp, or Bj-[lys-ile-arg-ala-his-pro-his-xr-(pro)n]m-Rp, or a derivative or fragment thereof, wherein B is a first chemical moiety, j is 0 or 1, n is an integer from 1-10, X is any amino acid, r is an integer from 0 to 2, m is an integer from 1 to 3, R is a second chemical moiety, p is 0 or 1, and [lys-ile-arg-ala-his-pro-his-xr-(pro)n] is the retro-inverso peptide of [(Pro)n-Xr-His-Pro-His-Ala-Arg-Ile-Lys].
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: September 3, 2019
    Assignee: Cancer Research Technology Limited
    Inventors: Satu Vainikka, George Steven Morris, Samuel Ogunsalu, Gabriella Castoria, Antimo Migliaccio, Ferdinando Auricchio
  • Publication number: 20180271933
    Abstract: The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro)n-His-Pro-His-Ala-Arg-Ile-Lys]m-Y. The peptides are for medical use, in particular as anti-tumoral agents.
    Type: Application
    Filed: March 12, 2018
    Publication date: September 27, 2018
    Inventors: Ferdinando AURICCHIO, Antimo Migliaccio
  • Patent number: 9919023
    Abstract: The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro)n-His-Pro-His-Ala-Arg-Ile-Lys]m-Y. The peptides are for medical use, in particular as anti-tumoral agents.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: March 20, 2018
    Assignee: Cancer Research Technology Limited
    Inventors: Ferdinando Auricchio, Antimo Migliaccio
  • Publication number: 20150202249
    Abstract: The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro)n-His-Pro-His-Ala-Arg-Ile-Lys]m-Y. The peptides are for medical use, in particular as anti-tumoral agents.
    Type: Application
    Filed: December 18, 2014
    Publication date: July 23, 2015
    Inventors: Ferdinando Auricchio, Antimo Migliaccio
  • Publication number: 20100189776
    Abstract: The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro)n-His-Pro-His-Ala-Arg-Ile-Lys]m-Y. The peptides are for medical use, in particular as anti-tumoral agents.
    Type: Application
    Filed: March 11, 2008
    Publication date: July 29, 2010
    Applicant: CANCER RESEARCH TECHNOLOGY LTD
    Inventors: Ferdinando Auricchio, Antimo Migliaccio